LXR beta/NR1H2 Antibody Blocking Peptide

• Reactivity: Hu
• Applications: AC
• Concentration: 0.2 mg/ml

LXR beta/NR1H2 Antibody Blocking Peptide Summary

• Description: A blocking peptide containing 14 amino acids near the amino terminus of human LXR-B.

  Source: Synthetic

  (Accession #: P55055)

• Source: Synthetic
• Protein/Peptide Type: Antibody Blocking Peptide
• Gene: NR1H2
• Purity: N/A

Applications/Dilutions

• Dilutions:
  • Antibody Competition
• Application Notes: This peptide is useful as a blocking peptide for NBP1-76256.
  
  For further blocking peptide related protocol, click here.

Packaging, Storage & Formulations

• Storage: Store at -20C. Avoid freeze-thaw cycles.
• Buffer: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
• Preservative: 0.02% Sodium Azide
• Concentration: 0.2 mg/ml
• Purity: N/A

Alternate Names for LXR beta/NR1H2 Antibody Blocking Peptide

• Liver X receptor beta
• LXR beta
• LXR-b
• NER-I
• NERliver X receptor-beta
• NR1H2
• nuclear orphan receptor LXR-beta
• Nuclear receptor NER
• Nuclear receptor subfamily 1 group H member 2
• nuclear receptor subfamily 1, group H, member 2
• oxysterols receptor LXR-beta
• RIP15
• steroid hormone-nuclear receptor NER
• Ubiquitously-expressed nuclear receptorLXRB
• UNR
• UNRLX receptor beta

Background

LXR beta is ubiquitously expressed. Liver X Receptors (LXRs) are oxysterol activated nuclear receptors which are involved in the regulation of cholesterol metabolism and bile acids. Two known isoforms, alpha and beta, are differentially expressed. The alpha isoform is predominantly expressed in liver.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.

Bioinformatics

• Gene Symbol: NR1H2